Intracoronary Low-Dose Thrombolysis in Primary PCI for STEMI: A Systematic Review and Meta-Analysis
- 1 October 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (10)
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus BurdenJACC, 2025
- Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic TimeJACC, 2020
- Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49)The American Journal of Cardiology, 2020
- Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial InfarctionJAMA, 2019
- Effect of Intracoronary Streptokinase Administered Immediately After Primary Percutaneous Coronary Intervention on Long-Term Left Ventricular Infarct Size, Volumes, and FunctionJACC, 2009